Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis

J. Berthiller, K. Straif, A. Agudo, W. Ahrens, A. Bezerra Dos Santos, S. Boccia, G. Cadoni, C. Canova, X. Castellsague, C. Chen, D. Conway, MP. Curado, L. Dal Maso, AW. Daudt, E. Fabianova, L. Fernandez, S. Franceschi, EE. Fukuyama, RB. Hayes, C....

. 2016 ; 45 (3) : 835-45. [pub] 20150730

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, U.S. Gov't, Non-P.H.S., práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18011344

BACKGROUND: Cigarette smoking is a major risk factor for head and neck cancer (HNC). To our knowledge, low cigarette smoking (<10 cigarettes per day) has not been extensively investigated in fine categories or among never alcohol drinkers. METHODS: We conducted a pooled analysis of individual participant data from 23 independent case-control studies including 19 660 HNC cases and 25 566 controls. After exclusion of subjects using other tobacco products including cigars, pipes, snuffed or chewed tobacco and straw cigarettes (tobacco product used in Brazil), as well as subjects smoking more than 10 cigarettes per day, 4093 HNC cases and 13 416 controls were included in the analysis. The lifetime average frequency of cigarette consumption was categorized as follows: never cigarette users, >0-3, >3-5, >5-10 cigarettes per day. RESULTS: Smoking >0-3 cigarettes per day was associated with a 50% increased risk of HNC in the study population [odds ratio (OR) = 1.52, 95% confidence interval (CI): (1.21, 1.90). Smoking >3-5 cigarettes per day was associated in each subgroup from OR = 2.01 (95% CI: 1.22, 3.31) among never alcohol drinkers to OR = 2.74 (95% CI: 2.01, 3.74) among women and in each cancer site, particularly laryngeal cancer (OR = 3.48, 95% CI: 2.40, 5.05). However, the observed increased risk of HNC for low smoking frequency was not found among smokers with smoking duration shorter than 20 years. CONCLUSION: Our results suggest a public health message that low frequency of cigarette consumption contributes to the development of HNC. However, smoking duration seems to play at least an equal or a stronger role in the development of HNC.

Aviano Cancer Centre Aviano Italy

Boston University School of Public Health Boston MA USA

Bremen Institute for Prevention Research and Social Medicine Bremen Germany

Brown University Providence RI USA

Cancer Registry of Norway Oslo Norway

Cancer Research Centre Moscow Russia

Catalan Institute of Oncology Barcelona Spain

Catalan Institute of Oncology L'Hospitalet de Llobregat Barcelona Spain

College of Public Health University of Iowa Iowa City IA USA

Croatian National Cancer Registry Zagreb Croatia

Dental School College of Medical Veterinary and Life Sciences University of Glasgow Glasgow UK

Departments of Epidemiology Environmental Health Sciences and Urology Schools of Public Health and Medicine and Comprehensive Cancer Center University of Michigan Ann Arbor MI USA

Division of Epidemiology New York University School Of Medicine New York NY USA

Escola Nacional de Saude Publica Fundacao Oswaldo Cruz Rio de Janeiro Brazil

Fred Hutchinson Cancer Research Center Seattle WA USA

Head and Neck Surgery Department Institute of Otorhinolaryngology Università Cattolica del Sacro Cuore Rome Italy

Hospital de Clinicas de Porto Alegre Porto Alegre Brazil

Huntsman Cancer Institute University of Utah School of Medicine Salt Lake City UT USA and University of Utah School of Medicine Salt Lake City UT USA

Institute of Hygiene and Epidemiology Prague Czech Republic

Institute of Occupational Medicine Lodz Poland

Institute of Oncology and Radiobiology La Havana Cuba Instituto do Câncer do Estado de Sao Paulo Sao Paulo Brazil

Institute of Oncology Angel H Roffo University of Buenos Aires Buenos Aires Argentina

Institute of Public Health Section of Hygiene Università Cattolica del Sacro Cuore Rome Italy L'Istituto di Ricovero e Cura a Carattere Scientifico Rome Italy

Institute of Social and Preventive Medicine Lausanne Switzerland

Instituto do Câncer do Estado de Sao Paulo Sao Paulo Brazil

International Agency for Research on Cancer Lyon France

International Agency for Research on Cancer Lyon France Pôle Information Médicale Evaluation Recherche Hospices Civils de Lyon France

International Prevention Research Institute Lyon France

Istituto Di Ricovero e Cura a Carattere Scientific IRCCS Milan Italy

M Skasodowska Curie Memorial Cancer Center and Institute of Oncology Department of Cancer Epidemiology and Prevention Warsaw Poland

National Cancer Institute National Institutes of Health Bethesda MD USA

National Institute of Environmental Health Budapest Hungary

National Institute of Public Health Bucharest Romania

Penn State College of Medicine Hershey PA USA

Regional Authority of Public Health Banska Bystrica Slovakia

Tisch Cancer Institute and Institute of Translational Epidemiology Icahn School of Medicine at Mount Sinai New York NY USA

Trinity College School of Dental Science Dublin Ireland

UCLA School of Public Health Los Angeles CA USA

UNC School of Public Health Chapel Hill NC USA

Universidade de Sao Paulo Sao Paulo Brazil

Universidade Federal de Pelotas Pelotas Brazil

University of Aberdeen Dental School Aberdeen UK

University of Athens School of Medicine Athens Greece

University of Heidelberg Heidelberg Germany

University of Newcastle Newcastle UK

University of Padua Padua Italy

University of Turin Turin Italy

University of Utah School of Medicine Salt Lake City UT USA

UT M D Anderson Cancer Center Houston TX USA

Washington State University College of Pharmacy Spokane WA USA

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18011344
003      
CZ-PrNML
005      
20180417153540.0
007      
ta
008      
180404s2016 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ije/dyv146 $2 doi
035    __
$a (PubMed)26228584
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Berthiller, Julien $u International Agency for Research on Cancer, Lyon, France, Pôle Information Médicale Evaluation Recherche, Hospices Civils de Lyon, France.
245    10
$a Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis / $c J. Berthiller, K. Straif, A. Agudo, W. Ahrens, A. Bezerra Dos Santos, S. Boccia, G. Cadoni, C. Canova, X. Castellsague, C. Chen, D. Conway, MP. Curado, L. Dal Maso, AW. Daudt, E. Fabianova, L. Fernandez, S. Franceschi, EE. Fukuyama, RB. Hayes, C. Healy, R. Herrero, I. Holcatova, K. Kelsey, K. Kjaerheim, S. Koifman, P. Lagiou, C. La Vecchia, P. Lazarus, F. Levi, J. Lissowska, T. Macfarlane, D. Mates, M. McClean, A. Menezes, F. Merletti, H. Morgenstern, J. Muscat, AF. Olshan, M. Purdue, H. Ramroth, P. Rudnai, SM. Schwartz, D. Serraino, O. Shangina, E. Smith, EM. Sturgis, N. Szeszenia-Dabrowska, P. Thomson, TL. Vaughan, M. Vilensky, Q. Wei, DM. Winn, V. Wünsch-Filho, ZF. Zhang, A. Znaor, G. Ferro, P. Brennan, P. Boffetta, M. Hashibe, YC. Lee,
520    9_
$a BACKGROUND: Cigarette smoking is a major risk factor for head and neck cancer (HNC). To our knowledge, low cigarette smoking (<10 cigarettes per day) has not been extensively investigated in fine categories or among never alcohol drinkers. METHODS: We conducted a pooled analysis of individual participant data from 23 independent case-control studies including 19 660 HNC cases and 25 566 controls. After exclusion of subjects using other tobacco products including cigars, pipes, snuffed or chewed tobacco and straw cigarettes (tobacco product used in Brazil), as well as subjects smoking more than 10 cigarettes per day, 4093 HNC cases and 13 416 controls were included in the analysis. The lifetime average frequency of cigarette consumption was categorized as follows: never cigarette users, >0-3, >3-5, >5-10 cigarettes per day. RESULTS: Smoking >0-3 cigarettes per day was associated with a 50% increased risk of HNC in the study population [odds ratio (OR) = 1.52, 95% confidence interval (CI): (1.21, 1.90). Smoking >3-5 cigarettes per day was associated in each subgroup from OR = 2.01 (95% CI: 1.22, 3.31) among never alcohol drinkers to OR = 2.74 (95% CI: 2.01, 3.74) among women and in each cancer site, particularly laryngeal cancer (OR = 3.48, 95% CI: 2.40, 5.05). However, the observed increased risk of HNC for low smoking frequency was not found among smokers with smoking duration shorter than 20 years. CONCLUSION: Our results suggest a public health message that low frequency of cigarette consumption contributes to the development of HNC. However, smoking duration seems to play at least an equal or a stronger role in the development of HNC.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a pití alkoholu $x epidemiologie $7 D000428
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a kouření cigaret $x epidemiologie $7 D000073865
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nádory hlavy a krku $x epidemiologie $7 D006258
650    _2
$a lidé $7 D006801
650    _2
$a logistické modely $7 D016015
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a odds ratio $7 D016017
650    _2
$a veřejné zdravotnictví $7 D011634
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Straif, Kurt $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Agudo, Antonio $u Catalan Institute of Oncology (ICO-IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
700    1_
$a Ahrens, Wolfgang $u Bremen Institute for Prevention Research and Social Medicine (BIPS), Bremen, Germany.
700    1_
$a Bezerra Dos Santos, Alexandre $u Instituto do Câncer do Estado de Sao Paulo (ICESP), Sao Paulo, Brazil.
700    1_
$a Boccia, Stefania $u Institute of Public Health, Section of Hygiene, Università Cattolica del Sacro Cuore, Rome, Italy, L'Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
700    1_
$a Cadoni, Gabriella $u Head and Neck Surgery Department, Institute of Otorhinolaryngology, Università Cattolica del Sacro Cuore, Rome, Italy.
700    1_
$a Canova, Cristina $u University of Padua, Padua, Italy.
700    1_
$a Castellsague, Xavier $u Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain, CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
700    1_
$a Chen, Chu $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
700    1_
$a Conway, David $u Dental School, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
700    1_
$a Curado, Maria Paula $u International Prevention Research Institute, Lyon, France.
700    1_
$a Dal Maso, Luigino $u Aviano Cancer Centre, Aviano, Italy.
700    1_
$a Daudt, Alexander W $u Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.
700    1_
$a Fabianova, Eleonora $u Regional Authority of Public Health, Banska Bystrica, Slovakia.
700    1_
$a Fernandez, Leticia $u Institute of Oncology and Radiobiology, La Havana, Cuba, Instituto do Câncer do Estado de Sao Paulo (ICESP), Sao Paulo, Brazil.
700    1_
$a Franceschi, Silvia $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Fukuyama, Erica E $u Instituto do Câncer do Estado de Sao Paulo (ICESP), Sao Paulo, Brazil.
700    1_
$a Hayes, Richard B $u Division of Epidemiology, New York University School Of Medicine, New York, NY, USA.
700    1_
$a Healy, Claire $u Trinity College School of Dental Science, Dublin, Ireland.
700    1_
$a Herrero, Rolando $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Holcatova, Ivana $u Institute of Hygiene and Epidemiology, Prague, Czech Republic.
700    1_
$a Kelsey, Karl $u Brown University, Providence, RI, USA.
700    1_
$a Kjaerheim, Kristina $u Cancer Registry of Norway, Oslo, Norway.
700    1_
$a Koifman, Sergio $u Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
700    1_
$a Lagiou, Pagona $u University of Athens School of Medicine, Athens, Greece.
700    1_
$a La Vecchia, Carlo $u Istituto Di Ricovero e Cura a Carattere Scientific IRCCS, Milan, Italy.
700    1_
$a Lazarus, Philip $u Washington State University College of Pharmacy, Spokane, WA, USA.
700    1_
$a Levi, Fabio $u Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital (CHUV), Lausanne, Switzerland.
700    1_
$a Lissowska, Jolanta $u M. Skasodowska-Curie Memorial Cancer Center and Institute of Oncology, Department of Cancer Epidemiology and Prevention, Warsaw, Poland.
700    1_
$a Macfarlane, Tatiana $u University of Aberdeen Dental School, Aberdeen, UK.
700    1_
$a Mates, Dana $u National Institute of Public Health, Bucharest, Romania.
700    1_
$a McClean, Michael $u Boston University School of Public Health, Boston, MA, USA.
700    1_
$a Menezes, Ana $u Universidade Federal de Pelotas, Pelotas, Brazil.
700    1_
$a Merletti, Franco $u University of Turin, Turin, Italy.
700    1_
$a Morgenstern, Hal $u Departments of Epidemiology, Environmental Health Sciences, and Urology, Schools of Public Health and Medicine, and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
700    1_
$a Muscat, Joshua $u Penn State College of Medicine, Hershey, PA, USA.
700    1_
$a Olshan, Andrew F $u UNC School of Public Health, Chapel Hill, NC, USA.
700    1_
$a Purdue, Mark $u National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
700    1_
$a Ramroth, Heribert $u University of Heidelberg, Heidelberg, Germany.
700    1_
$a Rudnai, Peter $u National Institute of Environmental Health, Budapest, Hungary.
700    1_
$a Schwartz, Stephen M $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
700    1_
$a Serraino, Diego $u Aviano Cancer Centre, Aviano, Italy.
700    1_
$a Shangina, Oxana $u Cancer Research Centre, Moscow, Russia.
700    1_
$a Smith, Elaine $u College of Public Health, University of Iowa, Iowa City, IA, USA.
700    1_
$a Sturgis, Erich M $u UT-M.D. Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Szeszenia-Dabrowska, Neonila $u Institute of Occupational Medicine, Lodz, Poland.
700    1_
$a Thomson, Peter $u University of Newcastle, Newcastle, UK.
700    1_
$a Vaughan, Thomas L $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
700    1_
$a Vilensky, Marta $u Institute of Oncology Angel H. Roffo, University of Buenos Aires, Buenos Aires, Argentina.
700    1_
$a Wei, Qingyi $u UT-M.D. Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Winn, Deborah M $u National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
700    1_
$a Wünsch-Filho, Victor $u Universidade de Sao Paulo, Sao Paulo, Brazil.
700    1_
$a Zhang, Zuo-Feng $u UCLA School of Public Health, Los Angeles, CA, USA.
700    1_
$a Znaor, Ariana $u Croatian National Cancer Registry, Zagreb, Croatia.
700    1_
$a Ferro, Gilles $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Brennan, Paul $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Boffetta, Paolo $u Tisch Cancer Institute and Institute of Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
700    1_
$a Hashibe, Mia $u Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA and University of Utah School of Medicine, Salt Lake City, UT, USA.
700    1_
$a Lee, Yuan-Chin Amy $u University of Utah School of Medicine, Salt Lake City, UT, USA amy.lee@utah.edu.
773    0_
$w MED00002316 $t International journal of epidemiology $x 1464-3685 $g Roč. 45, č. 3 (2016), s. 835-45
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26228584 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180417153638 $b ABA008
999    __
$a ok $b bmc $g 1288829 $s 1008156
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 45 $c 3 $d 835-45 $e 20150730 $i 1464-3685 $m International journal of epidemiology $n Int J Epidemiol $x MED00002316
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Možnosti archivace